关键词：过敏性鼻炎；机载过敏原；免疫球蛋白E（IgE）；药物治疗；免疫疗法
摘 要：Allergic rhinitis is caused by the interaction of airborne allergens with specific immunoglobulin E (IgE) type antibodies on the surface of mast cells. This interaction causes mast cells to release and synthesize chemicals, causing inflammation of the surrounding tissues. Typical symptoms include rhinorrhea, nasal itching, sneezing, and nasal congestion. Extranasal symptoms such as allergic conjunctivitis, itchy ears and palate, and asthma may also occur. Allergic rhinitis is treated using medications such as antihistamines, intranasal corticosteroids, or immunotherapies. Alternative forms of treatment are also employed in certain cases.
目 录：

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Overview: Allergic rhinitis

Understanding the disease

Classification of allergic rhinitis

Causes

Signs and symptoms

Risk factors

Diagnosis and testing

Treatment

Epidemiology

Economic burden and impact on quality of life

PART 06: Pipeline analysis

Information on pipeline candidates

Clinical trial information of allergic rhinitis

PART 07: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 08: Market segmentation based on class of drugs

Antihistamines

Intranasal corticosteroids

Immunotherapies

Global antihistamines drugs market

Global intranasal corticosteroids drugs market

Global immunotherapies drugs market

PART 09: Market segmentation by route of

administration

Oral

Parenteral

Intranasal

PART 10: Market segmentation by dosage form

Solid

Liquid

PART 11: Geographical segmentation

Global allergic rhinitis drugs market by geography 2015-

2020

Allergic rhinitis drugs market in Americas

Allergic rhinitis drugs market in EMEA

Allergic rhinitis drugs market in APAC

PART 12: Market drivers

Increased prevalence of allergic rhinitis

Rise in awareness about allergic rhinitis

High usage of tobacco

Presence of high unmet medical needs

PART 13: Impact of drivers

PART 14: Market challenges

Increased preference for CAM

Patent expiries and competition from generic drugs

Adverse effects of drugs

Poor patient adherence

PART 15: Impact of drivers and challenges

PART 16: Market trends

Self-medication using OTC products

Increased R&D

Intense competition

Strategic alliances

PART 17: Vendor landscape

Competitive scenario

Market share analysis 2015

AstraZeneca

GlaxoSmithKline

Meda Pharmaceuticals

Merck

Sanofi

UCB

Other prominent vendors

PART 18: Appendix

List of abbreviations

PART 19: Explore Technavio